A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
Saved in:
| Title: | A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. |
|---|---|
| Authors: | Puduvalli VK; Division of Neuro-Oncoology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Wu J; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Armstrong TS; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland., Vera E; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland., Wu J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Xu J; Division of Neuro-Oncoology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Giglio P; Division of Neuro-Oncoology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Colman H; Department of Neurosurgery, Huntsman Cancer Center, University of Utah, Salt Lake City, Utah., Walbert T; Department of Neurology and Neurosurgery, Henry Ford Health System, Detroit, Michigan., Raizer J; Department of Neurology, Northwestern University, Chicago, Illinois., Groves MD; Texas Oncology Austin Brain Tumor Center, Austin, Texas., Tran D; Department of Medicine, Washington University, St Louis, Missouri., Iwamoto F; Division of Neurooncology, Columbia University, New York, New York., Avgeropoulos N; Orlando Health UF Health Cancer Center, Orlando, Florida., Paleologos N; Advocate Health Care, Downers Grove, Illinois., Fink K; Baylor University Medical Center, Dallas, Texas., Peereboom D; Department of Medicine, Cleveland Clinic, Cleveland, Ohio., Chamberlain M; Department of Neurology, University of Washington, Seattle, Washington., Merrell R; Department of Neurology, North Shore University Health System, Evanston, Illinois., Penas Prado M; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yung WKA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gilbert MR; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland. |
| Source: | Neuro-oncology [Neuro Oncol] 2020 Oct 14; Vol. 22 (10), pp. 1505-1515. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noaa062 |
